Medical diligence uncovers fallopian tube cancer after abnormal Pap test

  • Department of Obstetrics, Gynecology, and Women’s Health, St. Louis University, St. Louis, MO, USA ROR

BMJ Case Reports, 12(7), e229762

DOI 10.1136/bcr-2019-229762 PMID 31345832

Abstract

The fallopian tube has received attention as an origin of high-grade pelvic malignancies. This is a case of bilateral fallopian tube cancer discovered after an abnormal Pap test. A 62-year-old woman with a history of one term delivery had atypical glandular cells on a Pap test. She had an unsatisfactory colposcopy and a normal transvaginal ultrasound. A loop electrode excision procedure and hysteroscopy with dilation and curettage revealed atypical glandular cells concentrated in floating balls. CA-125 was 10 U/mL. A robotic hysterectomy revealed histopathological stage IIIA serous carcinoma arising from both fallopian tubes. She received six cycles of carboplatin and paclitaxel. After chemotherapy, she has no evidence of disease at 5 years. Fallopian tube carcinoma is a differential diagnosis of abnormal glandular cells on a Pap test. Diagnosis by systematic pursuit of abnormal tests can lead to successful treatment of a small disease burden.

Topics

fallopian tube cancer, abnormal Pap test follow-up, atypical glandular cells, bilateral tubal cancer, pelvic malignancy diagnosis, serous tubal carcinoma, LEEP procedure findings, hysteroscopy cancer diagnosis, gynecologic oncology case, cervical screening incidental findings
PMID 31345832 31345832 DOI 10.1136/bcr-2019-229762 10.1136/bcr-2019-229762

Cite this article

Cara Buskmiller, Cline, B., & Xynos, F. (2019). Medical diligence uncovers fallopian tube cancer after abnormal Pap test. *BMJ case reports*, *12*(7), e229762. https://doi.org/10.1136/bcr-2019-229762

Related articles